Literature DB >> 31359055

IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome.

Shima Yasin1, Krista Solomon1, Scott W Canna2, Charlotte Girard-Guyonvarc'h3, Cem Gabay3, Eduardo Schiffrin4, Andrew Sleight4, Alexei A Grom1, Grant S Schulert1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31359055     DOI: 10.1093/rheumatology/kez284

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  14 in total

Review 1.  Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

Authors:  Courtney Crayne; Randy Q Cron
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 2.  Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.

Authors:  William G Ambler; Kabita Nanda; Karen Brandt Onel; Susan Shenoi
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

3.  Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.

Authors:  Guangbo Chen; Gail H Deutsch; Grant S Schulert; Hong Zheng; SoRi Jang; Bruce Trapnell; Pui Y Lee; Claudia Macaubas; Katherine Ho; Corinne Schneider; Vivian E Saper; Adriana Almeida de Jesus; Mark A Krasnow; Alexei Grom; Raphaela Goldbach-Mansky; Purvesh Khatri; Elizabeth D Mellins; Scott W Canna
Journal:  Arthritis Rheumatol       Date:  2022-05-31       Impact factor: 15.483

Review 4.  The 'cytokine storm': molecular mechanisms and therapeutic prospects.

Authors:  Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Trends Immunol       Date:  2021-07-01       Impact factor: 19.709

5.  Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019.

Authors:  Scott W Canna; Grant S Schulert; Adriana de Jesus; Alex Pickering; Hermine Brunner; Massimo Gadina; Stewart Levine; Raphaela Goldbach-Mansky; Jonathan Boutelle; Rashmi Sinha; Fabrizio DeBenedetti; Alexei Grom
Journal:  Pediatr Rheumatol Online J       Date:  2020-07-15       Impact factor: 3.054

6.  A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling.

Authors:  Suzhao Li; Liqiong Jiang; Karsten Beckmann; Jesper Falkesgaard Højen; Ulrich Pessara; Nicholas E Powers; Dennis M de Graaf; Tania Azam; Jared Lindenberger; Elan Z Eisenmesser; Stephan Fischer; Charles A Dinarello
Journal:  J Biol Chem       Date:  2021-04-03       Impact factor: 5.157

Review 7.  Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.

Authors:  Piotr Buda; Joanna Friedman-Gruszczyńska; Janusz Książyk
Journal:  Front Med (Lausanne)       Date:  2021-11-30

8.  The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.

Authors:  J M Krei; H J Møller; J B Larsen
Journal:  Clin Exp Immunol       Date:  2020-11-23       Impact factor: 4.330

Review 9.  Highways to hell: Mechanism-based management of cytokine storm syndromes.

Authors:  Scott W Canna; Randy Q Cron
Journal:  J Allergy Clin Immunol       Date:  2020-09-29       Impact factor: 10.793

Review 10.  The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still's Disease and Systemic Juvenile Idiopathic Arthritis.

Authors:  Charlotte Girard-Guyonvarc'h; Mathilde Harel; Cem Gabay
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.